Skip to main content
. 2021 Apr 1;11:629646. doi: 10.3389/fonc.2021.629646

Figure 2.

Figure 2

Meta-analysis of pooled odds ratios of an objective response to anti–PD-1 and anti–PD-L1 therapy. (A) anti–PD-1, (B) anti–PD-L1.